Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PRV-211 by Privo Technologies for Lip Cancer: Likelihood of Approval
PRV-211 is under clinical development by Privo Technologies and currently in Phase II for Lip Cancer. According to GlobalData, Phase...
Data Insights
PRV-211 by Privo Technologies for Oral Cavity (Mouth) Cancer: Likelihood of Approval
PRV-211 is under clinical development by Privo Technologies and currently in Phase II for Oral Cavity (Mouth) Cancer. According to...